Navigation Links
Encouraging First Data on New Targeted Treatment for Patients With Melanoma - the Deadliest Form of Skin Cancer
Date:6/1/2009

elanoma patients have been observed - Regression of metastatic lesions in every site to which melanoma commonly spreads, including to the liver, lung and bone - Disease control lasting up to 14 months with continuous therapy, with many responding patients still receiving treatment - Interim median progression-free survival of at least six months

By contrast, no treatment response was observed in a small group of patients without the BRAF mutation, and progression-free survival was less than two months, consistent with historical data.

Drug-related adverse events, including rash and photosensitivity, have been classified as mild in grade. Serious adverse events, including diagnosis of cutaneous squamous cell carcinoma, were observed in some patients after chronic treatment; however the safety profile has been warranted favourable for this population and the trial authorised to proceed to the next stage of investigation.

The PLX4032 data not only represent an important step forward in understanding and treating malignant melanoma, but also represent a significant advance in the use of biomarkers and diagnostic tools and the potential benefits of tailoring cancer treatment to individual patients.

About Plexxikon

Plexxikon is a leader in the structure-guided discovery and development of novel small molecule pharmaceuticals to treat human disease. The company's clinical stage programs include PLX4032 for the treatment of melanoma and colorectal cancer, PLX5568 for the treatment of polycystic kidney disease and PLX204 for the treatment of diabetes. Among the company's preclinical development programs, candidates are being developed for the treatment of rheumatoid arthritis, multiple sclerosis and other autoimmune diseases as well as for the treatment of pancreatic and metastatic breast cancer.

Plexxik
'/>"/>

SOURCE Roche
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Following Encouraging Results Anthera to Continue IMPACTS Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
2. Encouraging Gene Therapy Results in Genetic Form of Blindness
3. Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO
4. Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa
5. PTC Therapeutics Presents Encouraging Phase 1 Results of its Novel VEGF Inhibitor, PTC299, at 30th Annual San Antonio Breast Cancer Symposium
6. Exelixis Presents Encouraging Phase 1 Data For XL019, A Novel Selective Inhibitor of JAK2
7. New UNAIDS Report Offers Encouraging News, But Most HIV-Positive Mothers Still Not Getting the Care & Treatment They Need
8. Actress and Mother Jennifer Garner Kicks Off American Lung Associations Faces of Influenza Awareness Campaign, Encouraging Families to Get Vaccinated Against Influenza
9. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
10. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
11. Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... 18, 2013 The Open Paradigm Project, ... Occupy Psychiatry , and leading organizations in ... a social media campaign showcasing video testimonials by ... which focuses on pathology and illness rather than ... American Psychiatric Association,s (APA) rollout of its latest ...
(Date:5/17/2013)... May 17, 2013 The power of plants ... ways in which mankind depends on the plant kingdom, ... multifaceted exhibition Wild Medicine: Healing Plants ... on view from May 18 through September 8, 2013. ... The featured exhibition,s many attractions include a re-creation of ...
(Date:5/17/2013)... 2013  Lakeland Industries, Inc. (NASDAQ: LAKE ... industry, healthcare and to first responders on the federal, ... for the fiscal 2013 fourth quarter and year ended ... stock market close and will conduct a conference call ... (Logo: http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ) The ...
Breaking Medicine Technology:New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 2New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 3Wild Medicine On View at The New York Botanical Garden Through Sept. 8 2Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2
... Oct. 12 The U.S. Food and Drug ... relapse after patients with opioid dependence have undergone ... (Logo:   http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) ... administered by intramuscular injection once a month. Naltrexone ...
... 12 MedWOW.com is pleased to announce the addition ... auction medical equipment through online and/or live ... The new feature allows medical equipment auctioneers ... medical supplies on a multilingual, international website that attracts ...
Cached Medicine Technology:FDA Approves Injectable Drug to Treat Opioid-Dependent Patients 2MedWOW International Medical Equipment Platform Adds Auction Promotion Feature 2
(Date:5/21/2013)... (PRWEB) May 21, 2013 The Michigan ... meeting in Lapeer on , June 11th. , Meeting ... Location: Lapeer Regional Medical Center,     Conference Room 5 (Lower ... These meetings are designed to assist people with lupus ... one another, and to get a better understanding of ...
(Date:5/21/2013)... According to the Center for Disease Control and ... year. Over 800,000 of these bites require medical attention, ... should be aware of the danger that dog bites pose ... and children may sustain more serious injuries than an adult. ... the ages of 5 and 9 are at the greatest ...
(Date:5/20/2013)... Heritage Woods of Gurnee , a BMA ... hosting Breakfast and Bingo at 8:30 a.m. on Friday, ... 3775 Grand Ave. in Gurnee, Illinois, serves older adults ... some help to maintain their independence. , "Come and ... says Tammy Temaner-Rosas, Director of Marketing for Heritage Woods ...
(Date:5/20/2013)... May 20, 2013 When people ... not always to become a celebrity. New Jersey ... 2013 ABC News report (“Chris Christie Says Lap ... clear that the surgery was not done so ... gain celebrity status as a former lap band ...
(Date:5/20/2013)... 20, 2013 In order to prepare for ... wellness team from DrSmartphoneMD launched an article series to raise ... The series launched with the precautions that need ... the DrSmartphoneMD program are not one of the 3.5 million ... more than 90% of all skin cancer cases are associated ...
Breaking Medicine News(10 mins):Health News:Personal Injury Law Firm Announces New Informational Graphic Regarding Dog Bite Injuries 2Health News:Heritage Woods of Gurnee Affordable Assisted Living Community to Host Breakfast and Bingo 2Health News:The Lap Band Center: Dr. Atul Madan Applauds Chris Christie's Dedication to Family and Loss of 30 Pounds After Lap Band Surgery 2Health News:The Lap Band Center: Dr. Atul Madan Applauds Chris Christie's Dedication to Family and Loss of 30 Pounds After Lap Band Surgery 3Health News:Combat Skin Cancer In Summer Months 2
... , SAN FRANCISCO, Dec. 16 ... software and professional services solutions for the healthcare industry, ... division. Quantros has named software industry veteran Michael Tulloch, ... work from the company,s new Marlborough, MA office. , ...
... Boston University School of Medicine,s (BUSM) Pulmonary Center has ... Heart, Lung, and Blood Institute to derive stem cells ... Darrell Kotton, MD, associate professor of medicine and ... medicine, are the principal investigators of this new grant ...
... A ... impact on employee presenteeism and bottom line benefits. , ... Minneapolis, MN (PRWEB) December 16, 2009 -- A ... employee participation in health and wellness programs by implementing an incentive program. ...
... Two million screenings conducted through national AAD program ... from melanoma, the deadliest form of skin cancer, almost every ... That,s why thousands of dermatologists across the country offer free ... of Dermatology,s (AAD) National Melanoma/Skin Cancer Screening Program. The program ...
... ... the world,s largest online community for physicians, today announced the ... MD Social Media Conversations ." The report examines physician ... complete analysis of a variety of topics, including the therapies ...
... , , WILMINGTON, Delaware, December ... to outsource their accurate forecast models,for new and inmarket ... solutions to various players. These pharma,forecasting solutions are designed ... These have a substantial impact on pricing, launch, product ...
Cached Medicine News:Health News:Safety and Quality Software Developer Quantros, Inc. Launches Healthcare IT Consulting Division 2Health News:Boston University School of Medicine's pulmonary center receives $1.4 million grant 2Health News:Hallmark Insights' Employer Survey Reveals Cost-Savings Benefits of Health & Wellness Programs 2Health News:Dermatologists Reach Skin Cancer Screening Milestone 2Health News:Dermatologists Reach Skin Cancer Screening Milestone 3Health News:Sermo Vitals Report(TM) Quantifies One Year of Physician Conversation About Diabetes 2Health News:Sermo Vitals Report(TM) Quantifies One Year of Physician Conversation About Diabetes 3Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 2Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 3
... membrane parasite soluble lysate ... as antigen. Since this ... than the recombinant kit, ... use two ELISA techniques ...
The Cellabs T. cruzi IgG CELISA is a direct ELISA kit designed to detect antibodies produced during T. cruzi infections (Chagas disease)....
... The dual-electrode SPL defibrillator lead ... design, offering the flexibility and ... Designed for the physician who ... shocking coils, the SPL lead ...
... The Medtronic Subcutaneous Lead ... implanted subcutaneously with the use ... Model 6996T. Improved SQ design ... DFTs, a fast and easy ...
Medicine Products: